Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.48 |
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TNKS | O95271 | 1/20 | 0.38 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31672181 | 1.00 | CYP2A6 (0.48) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL13342447 | 0.87 | MAPT (0.48) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL3052012 | 0.81 | GPR3 (0.48) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL9537092 | 0.78 | CYP2A6 (0.46) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL25165146 | 0.78 | GPR3 (0.45) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL30705823 | 0.77 | CYP2A6 (0.48) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL9525819 | 0.77 | CYP2A6 (0.48) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL549009 | 0.74 | LMNA (0.57) | CYP2A6MEN1BLMKMT2ATDP1 | |
| SCHEMBL18767343 | 0.74 | KDM4E (0.46) | CYP2A6GPR3MEN1BLMKMT2A | |
| SCHEMBL1636538 | 0.74 | GPR3 (0.68) | GPR3MEN1BLMKMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12054470-B2 | Photoswitchable dibenzothienylmethyl triphenylphosphonium derivatives and methods of treating cancer therewith | SAINT LOUIS UNIVERSITY (US) | 2024-08-06 | — | — | US | disclosed |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| US-20210147378-A1 | PHOTOSWITCHABLE DIBENZOTHIENYLMETHYL TRIPHENYLPHOSPHONIUM DERIVATIVES AND METHODS OF TREATING CANCER THEREWITH | SAINT LOUIS UNIVERSITY (US) | 2021-05-20 | — | — | US | disclosed |
| US-20210024526-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNITED STATES DEPARTMENT OF ENERGY | 2021-01-28 | — | — | US | disclosed |
| US-10851106-B2 | Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials | ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-12-01 | — | — | US | disclosed |
| EP-3428171-B1 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-09-16 | — | — | EP | disclosed |
| US-10703768-B2 | Compound and color conversion film comprising same | LG CHEM, LTD. (KR) | 2020-07-07 | — | — | US | disclosed |
| US-20200071330-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNITED STATES DEPARTMENT OF ENERGY | 2020-03-05 | — | — | US | disclosed |
| WO-2019199911-A1 | PHOTOSWITCHABLE DIBENZOTHIENYLMETHYL TRIPHENYLPHOSPHONIUM DERIVATIVES AND METHODS OF TREATING CANCER THEREWITH | SAINT LOUIS UNIVERSITY (US) | 2019-10-17 | — | — | WO | disclosed |
| US-10392387-B2 | Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-08-27 | — | — | US | disclosed |
| EP-0183439-B1 | POLYCYCLIC COMPOUNDS, THEIR PREPARATION AND USE AND FORMULATIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-02-03 | — | — | EP | disclosed |
| US-5075455-A | Microbiocides, antitumor agents | BURROUGHS WELLCOME CO. (US) | 1991-12-24 | — | — | US | disclosed |
| US-5049581-A | Dibenzofurans having anti-tumor activity | BURROUGHS WELLCOME CO. (US) | 1991-09-17 | — | — | US | disclosed |
| US-5017600-A | Antitumor | BURROUGHS WELLCOME CO. (US) | 1991-05-21 | — | — | US | disclosed |
| US-5008286-A | Antitumor agents | BURROUGHS WELLCOME CO. (US) | 1991-04-16 | — | — | US | disclosed |
| US-4970227-A | ANTITUMOR | BURROUGHS WELLCOME CO. (US) | 1990-11-13 | — | — | US | disclosed |
| US-4965285-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1990-10-23 | — | — | US | disclosed |
| US-4866070-A | ANTITUMOR AGENT | BURROUGHS WELLCOME CO. (US) | 1989-09-12 | — | — | US | disclosed |
| EP-0183439-A2 | Polycyclic compounds, their preparation and use and formulations containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-06-04 | — | — | EP | disclosed |
| US-4106934-A | ELECTROGRAPHY | EASTMAN KODAK COMPANY (US) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024526-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | CYP2A6 3780/4885GPR3 4053/4885MEN1 2254/4885 |
| US-10703768-B2 | Compound and color conversion film comprising same | CYP1B1, FDFT1, FLI1 | CYP2A6 101/4885GPR3 4164/4885MEN1 221/4885 |
| US-20200071330-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | CYP2A6 3780/4885GPR3 4053/4885MEN1 2254/4885 |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | CYP2A6 3780/4885GPR3 4053/4885MEN1 2254/4885 |
| US-10851106-B2 | Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials | KCNK4, TRPC4, TBRG4 | CYP2A6 1388/4885GPR3 2219/4885MEN1 3856/4885 |
| US-10392387-B2 | Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials | NT5C, HTR3D, IK | CYP2A6 2585/4885GPR3 2067/4885MEN1 3952/4885 |
| US-12054470-B2 | Photoswitchable dibenzothienylmethyl triphenylphosphonium derivatives and methods of treating cancer therewith | RB1, NTPCR, DPYD | CYP2A6 909/4885GPR3 4503/4885MEN1 169/4885 |
| US-20210147378-A1 | PHOTOSWITCHABLE DIBENZOTHIENYLMETHYL TRIPHENYLPHOSPHONIUM DERIVATIVES AND METHODS OF TREATING CANCER THEREWITH | RB1, NTPCR, DPYD | CYP2A6 909/4885GPR3 4503/4885MEN1 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.